Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer.
about
Citrullination of proteins: a common posttranslational modification pathway induced by different nanoparticles in vitro and in vivoDetection of EpCAM-Negative and Cytokeratin-Negative Circulating Tumor Cells in Peripheral BloodCirculating tumor cells: approaches to isolation and characterizationCirculating tumor cells: finding the needle in the haystackCirculating tumors cells as biomarkers: progress toward biomarker qualificationCirculating Tumor Cell Isolation and Analysis.Clinical relevance and current challenges of research on disseminating tumor cells in cancer patientsDifferential peripheral blood gene expression profile based on Her2 expression on primary tumors of breast cancer patients.Fluorescent metal nanoshell and CK19 detection on single cell image.Circulating tumor cells in breast cancer.Circulating tumor cells in prostate cancer diagnosis and monitoring: an appraisal of clinical potential.Single-domain antibodies: a versatile and rich source of binders for breast cancer diagnostic approaches.mRNA-Seq of single prostate cancer circulating tumor cells reveals recapitulation of gene expression and pathways found in prostate cancer.CTC enumeration and characterization: moving toward personalized medicine.Cytokeratin19 induced by HER2/ERK binds and stabilizes HER2 on cell membranes.Use of Cytokeratin-19 Concentration to Assess Early Recurrence and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma following Radical Resection in Patients with a Low Serum Alpha-Fetoprotein Concentration.Clinical relevance and biology of circulating tumor cells.Keratin 13 Is Enriched in Prostate Tubule-Initiating Cells and May Identify Primary Prostate Tumors that Metastasize to the Bone.Molecular markers in peripheral blood of Iranian women with breast cancer.The potential for liquid biopsies in the precision medical treatment of breast cancer.Assessment of Cytokeratin-19 Gene Expression in Peripheral Blood of Breast Cancer Patients and Breast Cancer Cell Lines.Constitutive proteasomal degradation of TWIST-1 in epithelial-ovarian cancer stem cells impacts differentiation and metastatic potentialA Multiplexed Cytokeratin Analysis Using Targeted Mass Spectrometry Reveals Specific Profiles in Cancer-Related Pleural EffusionsCK19 mRNA in blood can predict non-sentinel lymph node metastasis in breast cancerRecent advances in the molecular characterization of circulating tumor cells.Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance.Organ-specific markers in circulating tumor cell screening: an early indicator of metastasis-capable malignancy.Circulating tumor cells as emerging tumor biomarkers in breast cancer.The connectivity of lymphogenous and hematogenous tumor cell dissemination: biological insights and clinical implications.Recent advances and prospects in the isolation by size of epithelial tumor cells (ISET) methodology.Enrichment, detection and clinical significance of circulating tumor cells.Technologies for detection of circulating tumor cells: facts and vision.Advanced technologies for studying circulating tumor cells at the protein level.Liquid biopsy of gastric cancer patients: circulating tumor cells and cell-free nucleic acids.A Strong Neutrophil Elastase Proteolytic Fingerprint Marks the Carcinoma Tumor Proteome.Liquid biopsy in cancer patients: advances in capturing viable CTCs for functional studies using the EPISPOT assay.Functional studies on circulating and disseminated tumor cells in carcinoma patientsSeparation of cancer cells from white blood cells by pinched flow fractionation.Multicolor detection of rare tumor cells in blood using a novel flow cytometry-based system.Cytokeratin 19 expression patterns of dentigerous cysts and odontogenic keratocysts.
P2860
Q23910338-A4F24A9D-97F7-42E3-BA08-994C13AF5D8EQ24597444-BD3851A9-2CB3-4D49-9BC8-8A240D77094BQ24631347-41B000A3-3A63-4AFB-B923-AEF65D470428Q24634952-023B6F46-026A-406B-B389-C0526D886581Q26852579-9841A353-38CD-4733-B6F3-FD15A2F65775Q30358229-CE532B3A-13D4-4370-A39C-002A3D0D8312Q33555492-FDF67AC7-64CF-4A5F-867B-D756C77776E9Q33960985-68AD02D7-2B80-430E-96C8-BF5ECDF06FA5Q34003016-CE2E1FEC-9014-4780-8BB2-44185BFBE274Q34077349-39217F8E-DFFC-4DB5-87CB-800ADB409BF6Q34108738-F77E48C8-3F57-4117-B57A-4E828A454389Q34330122-BEBF55BD-C506-48A6-9AED-9B8F21DBAB44Q34474138-C7041DBD-7874-48C8-A32C-FCC6F10F49FCQ34577724-A6FC18BE-07AC-47C6-83E4-A38743ECF712Q35167598-95470966-CB74-4079-8C10-F4AF923805DCQ35847118-775406F2-DE0F-4136-8077-D3249467FDDFQ35889548-63D8CEAC-FEA3-4B44-BCAA-473958A5F73CQ36155367-8C71DE88-AAA2-44B7-9CA1-B9C21DF82D15Q36695053-D94647D2-53B6-4F8F-A458-C72FFDA81316Q36849660-0DE0BA10-2FEB-402A-93BB-D90F177C01F9Q36856910-1CC9635F-BEB0-4ED3-B85B-912CCC43DA06Q36989636-6AE38042-0C31-4DE4-B317-7DC78F245EBBQ37112709-A45CC76E-09FA-41F7-BDBB-000B67CC7964Q37327521-C047AB24-3544-401E-AEAC-5CEB6CDCE137Q37693504-C302FDDA-75DE-4C39-8CCE-6A06369025C5Q37890969-E37554F5-B1A2-43F5-92E7-595E3EDDA71EQ37898107-FD3AC582-46FF-498F-86C1-CB4871500EA1Q37908134-A3869B0E-7E61-4B4C-92E6-C3DFAE63B433Q38016353-64152416-EABE-460D-8722-601165700F8CQ38085411-F8237A3B-2D81-41CF-88BA-557DE2B92501Q38102590-EA074099-9A69-40E4-95B0-C35D0C7B0E46Q38154493-DACB8AF6-BFFC-4FAE-AC27-43706948F3E3Q38160932-1061F7D3-5D64-4239-AD96-4CF022DE4437Q38201710-E38F5403-EE78-4021-8E5C-A38E6BE840FDQ38383767-3FE91D39-8E33-4930-8EFF-BD8598438D94Q38590310-8F29315F-95C2-4E57-BC7F-9E4CD2F79669Q38723767-2DAC74E2-7C9B-4B17-A346-56BCEB19E9CAQ38824158-4D520B56-D708-441B-ABF1-288996A5DFC6Q39044601-C7BAF901-22B2-4537-9868-0B564E3DC9CFQ39374813-9042D284-BBC3-41C6-AAF5-A5E4AC2CEC3E
P2860
Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Full-length cytokeratin-19 is ...... progression of breast cancer.
@en
Full-length cytokeratin-19 is ...... progression of breast cancer.
@nl
type
label
Full-length cytokeratin-19 is ...... progression of breast cancer.
@en
Full-length cytokeratin-19 is ...... progression of breast cancer.
@nl
prefLabel
Full-length cytokeratin-19 is ...... progression of breast cancer.
@en
Full-length cytokeratin-19 is ...... progression of breast cancer.
@nl
P2093
P2860
P356
P1476
Full-length cytokeratin-19 is ...... progression of breast cancer.
@en
P2093
Eric Barbotte
Grégoire Mercier
Jean-Pierre Vendrell
Klaus Pantel
Michel Fabbro
Monique Slijper
Olivier Pellé
William Jacot
P2860
P2888
P356
10.1186/BCR2326
P577
2009-06-23T00:00:00Z
P5875
P6179
1004714440